AI & Digital Health

Why Health Apps Aren’t Enough Anymore

June 4, 2026
|
by Dr. Ebot Eyong

Your sleep data sits in one place. Your glucose trends live somewhere else. Your stress levels are isolated. Each app tells you what’s happening in its own narrow world—but your body doesn’t work that way. Health is interconnected. Poor sleep affects glucose. Stress impacts blood pressure. Mental health influences weight. When these signals are disconnected, you’re left guessing.

Most people today use multiple health apps—one for sleep, another for glucose, and another for stress. On the surface, it feels like you’re in control. You’re tracking everything.

But here’s the problem: none of these apps talk to each other.

Your sleep data sits in one place. Your glucose trends live somewhere else. Your stress levels are isolated. Each app tells you what’s happening in its own narrow world—but your body doesn't work that way.

Health is interconnected.

Poor sleep affects glucose. Stress impacts blood pressure. Mental health influences weight. When these signals are disconnected, you’re left guessing.

That’s why tracking alone isn't enough anymore.

The future of health isn't about collecting more data. It’s about connecting it.

This is where a new category is emerging: Health Intelligence Infrastructure.

Instead of separate tools, imagine a system that brings everything together—analyzing patterns across sleep, glucose, stress, and more. A system that doesn’t just show numbers but explains relationships.

This is the shift from data trackingdatatracking to data understanding.

Platforms like eeMeds are built around this idea. Not as another app, but as a data brain that connects your health signals into one unified picture.

Because real health insight doesn't come from isolated metrics.

It comes from seeing how everything works together.

Explore More Publications

Continue exploring Dr. Ebot Eyong’s professional insights on healthcare regulation, FDA submissions, AI-enabled medical devices, quality systems, and global compliance strategy.

AI & Digital Health

Challenges in Medical Device AI Validation

June 18, 2026
|
Dr. Ebot Eyong

The most difficult aspect is ensuring that an AI system remains reliable after deployment as patient populations, clinical practices, and data characteristics evolve over time. This has led regulators to shift from a one-time validation model toward a lifecycle-based approach involving continuous monitoring and revalidation.

Read Article

AI & Digital Health

Regulatory Challenges and Solutions for AI-Enabled Medical Devices

February 9, 2025
|
By Dr. Ebot Eyong

Regulatory agencies worldwide are encountering significant obstacles in managing and supervising AI-enabled medical devices. This article explores AI/ML regulatory oversight, ethical concerns, bias, performance degradation, transparency, cross-site deployment, post-market surveillance, cybersecurity risks, and standardized validation.

Read Article

EU Regulatory Strategy

Case Study: EU MDR Transition Strategy - Remediation

August 13, 2026
|
by Dr. Ebot Eyong

How E&E Medicals Guided a Medical Device Manufacturer Through the Transition from the Medical Device Directive (MDD) to the European Medical Device Regulation (EU MDR 2017/745)

Read Article

EU Regulatory Strategy

EU Proposal to Revise MDR and IVDR: Implications for Innovation, Documentation, and Software Oversight

February 17, 2026
|
By Dr. Ebot Eyong

The European Commission has proposed a targeted revision of the Medical Device Regulation and In Vitro Diagnostic Regulation aimed at supporting innovation while reducing unnecessary administrative burden. This article explores the impact on technical documentation, manufacturers, implementation challenges, and software oversight.

Read Article